AGP Executive Report
Last update: an hour agoGhana Health Workforce: Ghana’s health minister says specialist medical training will be decentralised, with more postgraduate spots and better equipment outside major cities to improve access and accountability. Obesity Drug Race: Roche struck a deal with Hanmi for HM17321, a urocortin 2 analog aimed at weight loss while preserving lean mass—an attempt to move beyond “just” GLP-1-style weight reduction. Alzheimer’s Access: Eisai’s Leqembi IQLIK (subcutaneous) is now available for people starting treatment in mild Alzheimer’s, with Medicare Part D cost details and support programs highlighted. Medical Marijuana Expansion: Frederick County, Virginia opened the region’s first medical marijuana dispensary, with Ayr Wellness operating retail plus cultivation/processing under the state’s health service area model. Drug Safety & Counterfeits: India’s Nagpada police booked two men after an FDA probe found spurious Montair-LC tablets, with lab results showing wrong/undetected ingredients. Billing & Oversight: HHS-linked findings accuse UChicago Medicine of potentially improper billing in gender-affirming care for transgender minors, while a Ninth Circuit ruling says ERISA doesn’t preempt certain negligent misrepresentation claims tied to benefits verification calls. Workplace Privacy: A new report warns employers are using digital tracking tools to monitor workers’ productivity and communications, raising privacy concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
